Clinician Adoption

Benefits

Risks & contraindications

Other

Highlighted claims

• Clinicians valued risk ratios, medication cost information, and access to supporting evidence. — Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA
• Clinicians viewed familiar and intuitive interface design as reducing the learning burden. — Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA
• Embedded references increased clinician confidence by showing the source of the evidence. — Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA
• Education and reminders were considered necessary for clinician adoption. — Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA
• Scope-of-practice limits reduced DDInteract’s perceived utility for some nurses and clinicians under collaborative practice agreements. — Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA
• Clinicians worried that medication changes could conflict with other prescribers’ decisions. — Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA